Scleral Diseases Thesis Topics For MS Ophthalmology

sceleral pathologies thesis topics

This page brings together scleral disorders thesis topics for MS Ophthalmology covering episcleritis, anterior scleritis, necrotising scleritis, scleromalacia perforans, posterior scleritis, infectious scleritis, systemic associations, scleral imaging, postoperative scleral disease, traumatic injury and treatment outcomes. The topics are intended for MS Ophthalmology residents and are framed around designs that can usually be completed within one thesis period using routine ophthalmic patients, slit-lamp examination, anterior segment imaging, B-scan ultrasonography, microbiology and systemic evaluation already available in a teaching hospital. The strongest scleral disease research topics for MS Ophthalmology distinguish infectious from immune-mediated inflammation, define the anatomical subtype clearly and standardise imaging and clinical grading. Once a topic is shortlisted, the MS Ophthalmology scleral disorders protocol and MS Ophthalmology scleral disorders synopsis should specify the disease definition, reference standard, imaging method, systemic evaluation and feasible statistical plan.

Last reviewed and updated: September 2026 · 2026–27 admissions

Episcleritis

  1. Clinical profile of patients with simple and nodular episcleritis and its association with ocular surface disease at presentation: a hospital-based cross-sectional analytical study.
  2. Association between recurrent episcleritis and underlying systemic inflammatory disorders, using physician-confirmed systemic diagnosis as reference standard: a cross-sectional analytical study.
  3. Correlation of episcleritis severity with ocular pain score and conjunctival hyperaemia grade at initial presentation: a hospital-based cross-sectional correlation study.
  4. Comparison of clinical features, symptom severity and four-week resolution between simple and nodular episcleritis: a prospective comparative observational study.
  5. Association of episcleritis with seasonal variation, allergic eye disease and environmental dust exposure among patients attending a tertiary hospital: a cross-sectional analytical study.
  6. Diagnostic accuracy of the topical phenylephrine blanching test for differentiating episcleritis from anterior scleritis using specialist clinical examination as reference standard: a diagnostic accuracy study.
  7. Association between recurrent episcleritis and rheumatoid arthritis, systemic lupus erythematosus and other connective tissue disorders at presentation: a cross-sectional analytical study.
  8. Comparison of pain, tenderness and redness patterns between episcleritis and diffuse anterior scleritis at first examination: a comparative cross-sectional study.
  9. Correlation of recurrence frequency with duration of symptoms and systemic inflammatory disease in patients with recurrent episcleritis: a hospital-based cross-sectional correlation study.
  10. Association between unilateral and bilateral episcleritis with systemic disease detection during initial evaluation: a hospital-based cross-sectional analytical study.
  11. Comparison of ocular surface disease index scores and tear film parameters between patients with episcleritis and age-matched healthy controls: a comparative cross-sectional study.
  12. Correlation of episcleral vascular congestion graded clinically with anterior segment optical coherence tomography vascular changes at presentation: a cross-sectional correlation study.
  13. Comparison of four-week symptom resolution after topical lubricants versus topical corticosteroid treatment in uncomplicated episcleritis managed according to routine clinical indications: a prospective observational study.
  14. Association between delayed presentation and persistence of ocular pain or redness at four weeks in patients with episcleritis: a prospective observational study.
  15. Clinical characteristics and systemic associations of recurrent versus first-episode episcleritis among adults attending a tertiary eye clinic: a comparative cross-sectional study.
  16. Agreement between resident and consultant grading of episcleritis severity using standardized anterior segment photographs at presentation: an observer agreement study.
  17. Correlation of patient-reported pain severity with clinical congestion and tenderness in nodular episcleritis at initial presentation: a cross-sectional correlation study.
  18. Association of diabetes mellitus and hypertension with clinical severity and four-week resolution of episcleritis: a prospective observational study.
  19. Frequency and predictors of systemic disease detected after ophthalmic evaluation in patients presenting with recurrent or bilateral episcleritis: a cross-sectional analytical study.
  20. Comparison of recurrence within three months between patients with isolated episcleritis and those with confirmed systemic inflammatory disease: a prospective observational study.

Anterior Non-necrotising Scleritis

  1. Clinical profile and systemic associations of diffuse and nodular anterior scleritis among adults presenting to a tertiary eye hospital: a cross-sectional analytical study.
  2. Comparison of pain severity, scleral tenderness and visual acuity between diffuse and nodular anterior scleritis at presentation: a comparative cross-sectional study.
  3. Correlation of duration of symptoms before presentation with visual acuity and scleral inflammation severity in anterior scleritis: a cross-sectional correlation study.
  4. Association between anterior scleritis severity and rheumatoid arthritis, systemic lupus erythematosus and granulomatosis with polyangiitis at initial evaluation: a cross-sectional analytical study.
  5. Comparison of unilateral and bilateral anterior scleritis regarding systemic disease association and clinical severity at presentation: a comparative cross-sectional study.
  6. Correlation of ocular pain score with scleral congestion, tenderness and anterior segment optical coherence tomography findings in active anterior scleritis: a cross-sectional correlation study.
  7. Agreement between clinical grading and standardized anterior segment photographic grading of inflammation in patients with anterior scleritis: an observer agreement study.
  8. Association between delayed presentation beyond two weeks and reduced visual acuity at six weeks in patients with anterior scleritis: a prospective observational study.
  9. Comparison of six-week clinical resolution between patients receiving oral nonsteroidal anti-inflammatory drugs and systemic corticosteroids according to routine treatment indications: a prospective comparative observational study.
  10. Correlation of anterior scleral thickness measured by anterior segment optical coherence tomography with clinical inflammatory activity at presentation and six weeks: a prospective correlation study.
  11. Association between anterior scleritis and concurrent anterior uveitis, peripheral keratitis or ocular hypertension at initial presentation: a cross-sectional analytical study.
  12. Clinical predictors of reduced best corrected visual acuity at presentation in patients with non-necrotising anterior scleritis: a cross-sectional analytical study.
  13. Comparison of clinical severity and six-week response between idiopathic anterior scleritis and anterior scleritis associated with systemic inflammatory disease: a prospective comparative observational study.
  14. Association of smoking, diabetes mellitus and hypertension with severity of anterior scleritis at initial presentation: a cross-sectional analytical study.
  15. Correlation of scleral nodule size with pain severity and visual acuity in patients with nodular anterior scleritis: a cross-sectional correlation study.
  16. Comparison of anterior segment optical coherence tomography features between active anterior scleritis and episcleritis using specialist clinical diagnosis as reference standard: a diagnostic accuracy study.
  17. Frequency and clinical predictors of newly detected systemic autoimmune disease among patients presenting with anterior scleritis: a cross-sectional analytical study.
  18. Association between recurrent anterior scleritis and systemic inflammatory markers measured during active disease: a cross-sectional analytical study.
  19. Comparison of ocular complications at presentation between first-episode and recurrent anterior scleritis: a comparative cross-sectional study.
  20. Correlation of six-week reduction in scleral inflammation with improvement in pain and best corrected visual acuity after standard treatment: a prospective observational study.

Necrotising Scleritis and Scleromalacia Perforans

  1. Clinical profile and systemic disease associations of necrotising anterior scleritis among patients presenting to a tertiary referral centre: a cross-sectional observational study.
  2. Comparison of visual acuity, pain severity and ocular complications between necrotising and non-necrotising anterior scleritis at presentation: a comparative cross-sectional study.
  3. Association between rheumatoid arthritis duration and severity of scleromalacia perforans at ophthalmic presentation: a cross-sectional analytical study.
  4. Correlation of scleral thinning measured by anterior segment optical coherence tomography with clinical grading in eyes with necrotising scleritis: a cross-sectional correlation study.
  5. Frequency of peripheral ulcerative keratitis, anterior uveitis and ocular hypertension in patients with necrotising anterior scleritis at presentation: a cross-sectional observational study.
  6. Association between delayed presentation and extent of scleral necrosis in patients with necrotising anterior scleritis: a cross-sectional analytical study.
  7. Comparison of systemic inflammatory disease prevalence between patients with necrotising anterior scleritis and non-necrotising anterior scleritis: a comparative cross-sectional study.
  8. Clinical predictors of severe visual impairment in patients presenting with necrotising anterior scleritis: a cross-sectional analytical study.
  9. Correlation of pain severity with extent of scleral necrosis in patients with necrotising anterior scleritis at presentation: a cross-sectional correlation study.
  10. Comparison of clinical characteristics of painful necrotising scleritis and painless scleromalacia perforans in patients with systemic autoimmune disease: a comparative cross-sectional study.
  11. Agreement between slit-lamp clinical grading and anterior segment optical coherence tomography measurement of scleral thinning in necrotising scleritis: a method agreement study.
  12. Association between previous ocular surgery and location of scleral necrosis in patients presenting with necrotising scleritis: a cross-sectional analytical study.
  13. Comparison of six-week inflammation control between patients with necrotising scleritis receiving systemic corticosteroids alone and additional immunosuppressive therapy: a prospective observational study.
  14. Correlation of systemic inflammatory marker levels with clinical severity of necrotising anterior scleritis at presentation: a cross-sectional correlation study.
  15. Frequency of newly diagnosed rheumatoid arthritis and systemic vasculitis among patients presenting with necrotising scleritis: a cross-sectional observational study.
  16. Association between scleral necrosis extent at presentation and best corrected visual acuity at three months after standard treatment: a prospective observational study.
  17. Comparison of anterior segment optical coherence tomography features of scleromalacia perforans and active necrotising scleritis: a comparative cross-sectional study.
  18. Clinical predictors of scleral thinning progression during three months of follow-up in patients with necrotising anterior scleritis: a prospective observational study.
  19. Association between systemic immunosuppressive treatment at presentation and three-month stabilization of scleral thinning in autoimmune necrotising scleritis: a prospective observational study.
  20. Correlation between extent of scleral thinning and induced corneal astigmatism in patients with scleromalacia perforans: a cross-sectional correlation study.

Posterior Scleritis

  1. Clinical profile and presenting features of posterior scleritis among patients diagnosed in a tertiary ophthalmology service: a retrospective record-based observational study.
  2. Diagnostic accuracy of B-scan ultrasonography for posterior scleritis using combined specialist clinical and multimodal imaging diagnosis as reference standard: a diagnostic accuracy study.
  3. Correlation of posterior scleral thickness on B-scan ultrasonography with ocular pain and visual impairment at presentation: a cross-sectional correlation study.
  4. Comparison of clinical and imaging features of posterior scleritis and choroidal inflammatory disorders at initial presentation: a comparative cross-sectional study.
  5. Frequency of exudative retinal detachment, optic disc swelling and choroidal folds in posterior scleritis at presentation: a cross-sectional observational study.
  6. Association between duration of symptoms before presentation and best corrected visual acuity in patients with posterior scleritis: a cross-sectional analytical study.
  7. Comparison of optical coherence tomography findings between posterior scleritis with and without exudative retinal detachment: a comparative cross-sectional study.
  8. Correlation of subretinal fluid height on optical coherence tomography with visual acuity in posterior scleritis at presentation and six weeks: a prospective correlation study.
  9. Diagnostic performance of the ultrasonographic posterior scleral thickening sign for posterior scleritis using specialist diagnosis as reference standard: a diagnostic accuracy study.
  10. Comparison of posterior scleritis in patients with and without systemic autoimmune disease regarding presentation and six-week visual recovery: a prospective comparative observational study.
  11. Association between posterior scleritis and concurrent anterior scleritis at initial presentation: a cross-sectional analytical study.
  12. Correlation of choroidal thickness measured by enhanced-depth optical coherence tomography with inflammatory activity in posterior scleritis: a cross-sectional correlation study.
  13. Comparison of six-week reduction in subretinal fluid between posterior scleritis treated with systemic corticosteroids and nonsteroidal anti-inflammatory drugs according to clinical indication: a prospective observational study.
  14. Frequency and predictors of initial misdiagnosis in patients subsequently confirmed to have posterior scleritis: a retrospective record-based analytical study.
  15. Comparison of clinical features of posterior scleritis and central serous chorioretinopathy using specialist diagnosis as reference standard: a comparative diagnostic study.
  16. Association of optic disc swelling with presenting visual acuity and six-week visual recovery in posterior scleritis: a prospective observational study.
  17. Correlation of pain improvement with reduction in posterior scleral thickness after six weeks of treatment for posterior scleritis: a prospective correlation study.
  18. Clinical predictors of exudative retinal detachment among patients with posterior scleritis: a cross-sectional analytical study.
  19. Agreement between B-scan ultrasonography and optical coherence tomography in detecting posterior segment structural changes in posterior scleritis: a method agreement study.
  20. Comparison of first-episode and recurrent posterior scleritis regarding systemic associations, imaging findings and six-week visual outcome: a prospective comparative observational study.

Infectious Scleritis

  1. Clinical and microbiological profile of infectious scleritis presenting to a tertiary eye hospital, with organism identification by culture as reference standard: a cross-sectional observational study.
  2. Association between previous ocular surgery and microbiologically confirmed infectious scleritis among patients with active scleral inflammation: a cross-sectional analytical study.
  3. Comparison of clinical features of infectious and immune-mediated scleritis using microbiological culture and specialist diagnosis as reference standards: a comparative diagnostic study.
  4. Diagnostic accuracy of clinical features for predicting infectious scleritis using microbiological culture positivity as reference standard: a diagnostic accuracy study.
  5. Association between antecedent ocular trauma and bacterial or fungal infectious scleritis among patients presenting with scleral inflammation: a cross-sectional analytical study.
  6. Clinical profile of fungal scleritis following agricultural or vegetative matter injury and its three-month anatomical outcome: a prospective observational study.
  7. Comparison of microbiological yield from scleral scraping and associated corneal scraping in patients with suspected infectious scleritis: a diagnostic agreement study.
  8. Association between delay in initiation of antimicrobial treatment and scleral thinning at three months in microbiologically confirmed infectious scleritis: a prospective observational study.
  9. Comparison of pain, discharge and scleral necrosis between bacterial and fungal infectious scleritis at presentation: a comparative cross-sectional study.
  10. Correlation of initial scleral lesion size with three-month best corrected visual acuity in patients with infectious scleritis: a prospective correlation study.
  11. Frequency of infectious scleritis following pterygium surgery and its microbiological spectrum in a tertiary referral hospital: a retrospective record-based observational study.
  12. Association between diabetes mellitus and severity of microbiologically confirmed infectious scleritis at presentation: a cross-sectional analytical study.
  13. Comparison of culture-positive and culture-negative suspected infectious scleritis regarding clinical severity and three-month anatomical outcome: a prospective comparative observational study.
  14. Clinical predictors of fungal aetiology in patients presenting with suspected infectious scleritis using microbiological culture as reference standard: a diagnostic accuracy study.
  15. Association between concurrent keratitis and microbiological profile in patients with infectious scleritis: a cross-sectional analytical study.
  16. Correlation of scleral abscess size with presenting pain, visual acuity and three-month structural outcome in infectious scleritis: a prospective correlation study.
  17. Comparison of three-month outcomes of infectious scleritis occurring after ocular surgery versus after trauma: a prospective comparative observational study.
  18. Frequency and predictors of scleral thinning among patients treated for microbiologically confirmed infectious scleritis at three months: a prospective observational study.
  19. Agreement between initial clinical aetiological diagnosis and final microbiological diagnosis in patients with suspected infectious scleritis: an observer agreement study.
  20. Association between prior topical corticosteroid exposure and extent of scleral infection at presentation in microbiologically confirmed infectious scleritis: a cross-sectional analytical study.

Systemic Associations of Scleral Inflammation

  1. Prevalence of systemic autoimmune disease among patients presenting with scleritis and its association with anatomical subtype at initial evaluation: a cross-sectional analytical study.
  2. Association between rheumatoid arthritis activity and severity of anterior scleritis among patients with established rheumatoid arthritis: a cross-sectional analytical study.
  3. Clinical spectrum of scleritis associated with granulomatosis with polyangiitis and its relationship with systemic disease activity at presentation: a cross-sectional correlation study.
  4. Association between systemic lupus erythematosus and bilateral or recurrent scleritis among patients presenting to a tertiary eye hospital: a cross-sectional analytical study.
  5. Frequency of previously undiagnosed systemic autoimmune disease among patients presenting with first-episode scleritis: a cross-sectional observational study.
  6. Diagnostic yield of targeted systemic investigations in patients with recurrent, bilateral or necrotising scleritis using physician-confirmed systemic diagnosis as reference standard: a diagnostic accuracy study.
  7. Association between tuberculosis and recurrent scleral inflammation among patients evaluated in a tuberculosis-endemic tertiary hospital: a case-control study.
  8. Clinical features of presumed tubercular scleritis and their association with response to antitubercular treatment at three months: a prospective observational study.
  9. Comparison of scleral inflammation severity in patients with and without established systemic autoimmune disease at presentation: a comparative cross-sectional study.
  10. Association between elevated erythrocyte sedimentation rate and clinical severity of active scleritis at initial presentation: a cross-sectional analytical study.
  11. Correlation of C-reactive protein levels with pain severity and scleral inflammation grade in active immune-mediated scleritis: a cross-sectional correlation study.
  12. Association between recurrent scleritis and systemic vasculitis diagnosed during multidisciplinary evaluation: a cross-sectional analytical study.
  13. Comparison of ocular complications in idiopathic scleritis and scleritis associated with systemic inflammatory disease at presentation: a comparative cross-sectional study.
  14. Frequency of human immunodeficiency virus infection among patients with infectious or atypical scleritis and associated clinical characteristics: a cross-sectional observational study.
  15. Association between diabetes mellitus and infectious versus non-infectious scleritis among adults presenting with scleral inflammation: a case-control study.
  16. Clinical profile of scleritis associated with inflammatory bowel disease and its relationship with intestinal disease activity at presentation: a cross-sectional correlation study.
  17. Association between thyroid autoimmune disease and recurrent episcleritis or scleritis among patients attending a tertiary eye hospital: a cross-sectional analytical study.
  18. Comparison of systemic disease detection rates between patients with unilateral and bilateral scleritis: a comparative cross-sectional study.
  19. Clinical predictors of underlying systemic autoimmune disease among patients presenting with scleritis, using physician-confirmed diagnosis as reference standard: a diagnostic accuracy study.
  20. Association between duration of known systemic autoimmune disease and severity of scleritis at ophthalmic presentation: a cross-sectional analytical study.

Imaging and Diagnostic Differentiation

  1. Diagnostic accuracy of anterior segment optical coherence tomography for differentiating episcleritis from anterior scleritis using specialist clinical examination as reference standard: a diagnostic accuracy study.
  2. Correlation of anterior scleral thickness measured by anterior segment optical coherence tomography with clinical inflammation grade in active anterior scleritis: a cross-sectional correlation study.
  3. Comparison of anterior segment optical coherence tomography findings in diffuse, nodular and necrotising anterior scleritis at presentation: a comparative cross-sectional study.
  4. Agreement between two masked observers measuring scleral thickness on anterior segment optical coherence tomography in patients with scleritis: an inter-observer reliability study.
  5. Intra-observer repeatability of anterior scleral thickness measurements on optical coherence tomography in patients with active and inactive scleritis: a reliability study.
  6. Diagnostic accuracy of B-scan ultrasonography for differentiating posterior scleritis from choroidal and retinal inflammatory conditions using specialist diagnosis as reference standard: a diagnostic accuracy study.
  7. Correlation of B-scan ultrasonographic posterior coat thickness with optical coherence tomography subretinal fluid in posterior scleritis: a cross-sectional correlation study.
  8. Agreement between clinical scleral thinning estimation and anterior segment optical coherence tomography measurements in necrotising scleritis: a method agreement study.
  9. Comparison of scleral thickness measured in inflamed and fellow unaffected eyes of patients with unilateral anterior scleritis: a comparative cross-sectional study.
  10. Diagnostic performance of ocular tenderness, deep vascular congestion and phenylephrine non-blanching for identifying anterior scleritis using specialist examination as reference standard: a diagnostic accuracy study.
  11. Comparison of choroidal thickness between eyes with posterior scleritis and age-matched healthy controls using enhanced-depth optical coherence tomography: a comparative cross-sectional study.
  12. Correlation between choroidal folds on optical coherence tomography and ultrasonographic posterior scleral thickening in posterior scleritis: a cross-sectional correlation study.
  13. Diagnostic accuracy of standardized anterior segment photography for grading active anterior scleritis using slit-lamp specialist grading as reference standard: a diagnostic accuracy study.
  14. Inter-observer agreement between postgraduate residents and consultants in classifying anterior scleritis into diffuse, nodular and necrotising subtypes: an observer agreement study.
  15. Comparison of corneal topographic astigmatism between eyes with localised scleral thinning and fellow unaffected eyes: a comparative cross-sectional study.
  16. Correlation of scleral inflammation extent on standardized photography with pain and visual acuity at presentation: a cross-sectional correlation study.
  17. Diagnostic accuracy of combined clinical examination and B-scan ultrasonography for posterior scleritis using multimodal specialist diagnosis as reference standard: a diagnostic accuracy study.
  18. Agreement between B-scan ultrasonography and enhanced-depth optical coherence tomography for detecting posterior ocular coat thickening in suspected posterior scleritis: a method agreement study.
  19. Comparison of anterior scleral thickness in active scleritis, inactive previous scleritis and healthy controls using anterior segment optical coherence tomography: a comparative cross-sectional study.
  20. Correlation between reduction in optical coherence tomography-measured scleral thickness and clinical inflammation score after six weeks of treatment: a prospective correlation study.

Surgically Induced and Postoperative Scleral Disorders

  1. Clinical profile of surgically induced scleral inflammation following cataract, pterygium and glaucoma procedures presenting to a tertiary referral centre: a retrospective observational study.
  2. Association between previous pterygium surgery and scleral thinning or necrosis among patients presenting with localised scleral inflammation: a cross-sectional analytical study.
  3. Comparison of clinical features of surgically induced necrotising scleritis and postoperative infectious scleritis using microbiological evaluation as reference standard: a comparative diagnostic study.
  4. Clinical predictors of infectious aetiology in postoperative scleral inflammation using microbiological culture as reference standard: a diagnostic accuracy study.
  5. Association between time since ocular surgery and severity of scleral thinning at presentation in patients with surgically induced scleral disease: a cross-sectional analytical study.
  6. Comparison of scleral complications following bare sclera pterygium surgery and conjunctival autograft surgery in patients referred with postoperative scleral disease: a retrospective comparative study.
  7. Correlation of postoperative scleral defect size with induced corneal astigmatism in patients with localised scleral thinning: a cross-sectional correlation study.
  8. Frequency of surgically induced necrotising scleritis among patients presenting with scleral inflammation after ocular surgery: a retrospective observational study.
  9. Association between multiple previous ocular surgeries and severity of surgically induced scleral inflammation at presentation: a cross-sectional analytical study.
  10. Comparison of three-month visual and anatomical outcomes between infectious and immune-mediated postoperative scleritis: a prospective comparative observational study.
  11. Clinical characteristics of scleral melt following pterygium surgery and factors associated with severe thinning at presentation: a cross-sectional analytical study.
  12. Association between prior adjunctive antimetabolite exposure during ocular surgery and scleral thinning among patients with postoperative scleral complications: a case-control study.
  13. Correlation of anterior segment optical coherence tomography-measured scleral defect depth with clinical grading after pterygium surgery: a cross-sectional correlation study.
  14. Comparison of pain severity in surgically induced necrotising scleritis and postoperative scleral infection at presentation: a comparative cross-sectional study.
  15. Frequency and microbiological profile of postoperative infectious scleritis following pterygium surgery in a tertiary hospital: a retrospective record-based observational study.
  16. Association between delay in referral and scleral defect size among patients with postoperative infectious or necrotising scleritis: a cross-sectional analytical study.
  17. Comparison of three-month scleral stabilization after medical treatment in surgically induced inflammatory versus infectious scleral disease: a prospective comparative observational study.
  18. Clinical predictors of poor three-month visual outcome in patients presenting with postoperative scleral necrosis: a prospective observational study.
  19. Agreement between slit-lamp estimation and anterior segment optical coherence tomography measurement of postoperative scleral thinning: a method agreement study.
  20. Association between concurrent corneal involvement and three-month visual outcome in patients with postoperative scleral necrosis: a prospective observational study.

Traumatic and Structural Scleral Disorders

  1. Clinical profile of scleral injuries following occupational, agricultural and road traffic trauma presenting to a tertiary eye emergency service: a cross-sectional observational study.
  2. Association between mechanism of ocular trauma and location or extent of scleral injury at presentation: a cross-sectional analytical study.
  3. Comparison of presenting visual acuity and ocular complications between scleral lacerations caused by metallic and non-metallic objects: a comparative cross-sectional study.
  4. Association between delayed presentation after open globe scleral injury and best corrected visual acuity at three months: a prospective observational study.
  5. Correlation of scleral wound length with presenting and three-month visual acuity after traumatic scleral laceration: a prospective correlation study.
  6. Comparison of traumatic scleral injury patterns in agricultural workers and non-agricultural workers attending a tertiary hospital: a comparative cross-sectional study.
  7. Association between posterior scleral extension of an open globe injury and three-month visual outcome: a prospective observational study.
  8. Diagnostic accuracy of B-scan ultrasonography for detecting posterior segment abnormalities after repaired scleral injury using operative and follow-up findings as reference standard: a diagnostic accuracy study.
  9. Clinical predictors of retinal detachment at presentation among patients with traumatic scleral laceration: a cross-sectional analytical study.
  10. Association between intraocular foreign body and extent of scleral injury among patients presenting with penetrating ocular trauma: a cross-sectional analytical study.
  11. Comparison of visual outcomes at three months between zone-two and zone-three scleral injuries after primary repair: a prospective comparative observational study.
  12. Correlation of time from injury to primary repair with three-month best corrected visual acuity in traumatic scleral laceration: a prospective correlation study.
  13. Clinical profile of acquired scleral ectasia and its association with previous surgery, trauma and chronic inflammation: a cross-sectional observational study.
  14. Comparison of corneal astigmatism in eyes with localised scleral ectasia and unaffected fellow eyes: a comparative cross-sectional study.
  15. Correlation of scleral thinning severity with refractive error in patients with acquired scleral ectasia: a cross-sectional correlation study.
  16. Association between high myopia and posterior scleral structural changes on B-scan ultrasonography among adults attending a tertiary eye clinic: a cross-sectional analytical study.
  17. Comparison of posterior scleral contour abnormalities in high myopia and age-matched emmetropic controls using B-scan ultrasonography: a comparative cross-sectional study.
  18. Association between previous ocular trauma and localised scleral pigmentation, thinning or ectasia detected during routine examination: a cross-sectional analytical study.
  19. Agreement between clinical examination and anterior segment optical coherence tomography for detecting localised scleral thinning after healed ocular trauma: a method agreement study.
  20. Clinical predictors of poor three-month vision following repaired traumatic scleral injury in adults presenting to a tertiary eye hospital: a prospective observational study.

Treatment Response and Patient-reported Outcomes

  1. Correlation of reduction in ocular pain with clinical resolution of inflammation at six weeks in patients treated for anterior scleritis: a prospective correlation study.
  2. Comparison of six-week pain relief and inflammation control between oral indomethacin and oral ibuprofen in uncomplicated anterior scleritis treated according to routine clinical practice: a prospective observational study.
  3. Association between baseline clinical severity and need for systemic corticosteroid treatment in patients with non-necrotising anterior scleritis: a cross-sectional analytical study.
  4. Comparison of six-week visual improvement in idiopathic and systemic disease-associated anterior scleritis receiving standard treatment: a prospective comparative observational study.
  5. Correlation of anterior scleral thickness reduction with improvement in pain score after six weeks of anti-inflammatory treatment: a prospective correlation study.
  6. Association between treatment adherence and six-week resolution of scleral inflammation in patients receiving oral anti-inflammatory therapy: a prospective observational study.
  7. Frequency and predictors of treatment non-adherence among patients receiving systemic therapy for scleritis in a tertiary teaching hospital: a cross-sectional analytical study.
  8. Association between socioeconomic factors and delayed follow-up among patients treated for scleritis: a prospective observational study.
  9. Comparison of three-month vision-related quality of life between patients with anterior scleritis and age-matched healthy controls using a validated questionnaire: a comparative cross-sectional study.
  10. Correlation of ocular pain severity with vision-related quality of life in patients with active scleritis at presentation: a cross-sectional correlation study.
  11. Comparison of three-month quality-of-life improvement between patients with resolved and persistent scleritis after standard treatment: a prospective comparative observational study.
  12. Association between recurrent scleral inflammation and anxiety or functional limitation measured by validated questionnaires at presentation: a cross-sectional analytical study.
  13. Correlation between improvement in best corrected visual acuity and vision-related quality-of-life score after three months of treatment for scleritis: a prospective correlation study.
  14. Comparison of six-week clinical response between first-episode and recurrent anterior scleritis receiving standard anti-inflammatory treatment: a prospective comparative observational study.
  15. Association between baseline systemic inflammatory disease and failure to achieve complete clinical resolution by six weeks in anterior scleritis: a prospective observational study.
  16. Clinical predictors of persistent ocular pain at six weeks despite resolution of visible scleral inflammation: a prospective observational study.
  17. Comparison of three-month visual outcome between patients presenting within seven days and those presenting later with active scleritis: a prospective comparative observational study.
  18. Association between patient education regarding systemic disease evaluation and completion of physician referral within three months among patients with recurrent scleritis: a prospective observational study.
  19. Correlation of baseline pain, inflammation grade and visual acuity with time to clinical resolution within three months in anterior scleritis: a prospective correlation study.
  20. Association between missed follow-up visits and persistent inflammation or reduced vision at three months among patients treated for scleritis: a prospective observational study.

Not the ophthalmology subspeciality you need? Scleral disorders is one section of our full ophthalmology collection — the hub page lists every subspeciality, each with its own free topic list. Updated September 2026.

Check all Ophthalmology Thesis Topics →

📌 Updated for 2026–2027 MS Ophthalmology Scleral Disorders admissions

The list was reviewed for feasibility in departments where scleral research relies mainly on slit-lamp examination, anterior segment OCT, B-scan ultrasonography, microbiology and targeted systemic evaluation.

  • Many topics can be completed with routine examination, clinical photography, anterior segment OCT, B-scan ultrasonography, microbiological culture and physician-confirmed systemic diagnoses; advanced laboratory or molecular testing is not essential for most projects.
  • Cross-sectional, comparative, diagnostic-accuracy, agreement, retrospective and short prospective follow-up designs are usually more practical than rare-disease cohorts requiring prolonged observation.
  • Publication potential is strongest when infectious and immune-mediated disease are separated carefully, imaging measurements are standardised and systemic associations are confirmed rather than inferred from symptoms or screening tests alone.
Generate a protocol from any topic above

Select Generate Protocol → beside any title in the list above and receive a submission-ready document built around that topic, containing all eighteen components:

  • Introduction / Synopsis
  • Research Question
  • Aim of the Study
  • Primary Objective
  • Secondary Objectives
  • Materials and Methods
  • Inclusion Criteria
  • Exclusion Criteria
  • Sample Size Calculation
  • Methodology
  • Statistical Analysis
  • Ethical Considerations
  • Review of Literature
  • References
  • Gantt Chart / Study Timeline
  • Patient Information Sheet
  • Consent Form
  • Data Collection Form

Already have your thesis title?

Generate the full scleral disorders protocol directly — objectives, methodology, sample size, statistics, timeline, references and annexures.

Generate your protocol

Alongside scleral disorders protocols and synopses, support is also available for departmental presentations, journal club presentations, ethics committee presentations, and posters and oral presentations for medical conferences — for postgraduate residents, board trainees and research scholars across India and the GCC. Prepared by a practising doctor with long experience in medical publishing and thesis supervision.

Enquire on WhatsApp →

Scleral disorders research outside India

The topics above work as research questions anywhere — what changes is the document the institution expects, and who approves it before data collection begins. The Gulf equivalent of an Indian synopsis is the scleral disorders research proposal submitted to an institutional review board, and it ordinarily carries three sections an Indian synopsis does not: a Gantt chart, a budget and resources section, and a Declaration of Helsinki statement.

Board and residency programmes — country by country

Saudi Arabia — SCFHS and the Saudi Board. Residency and fellowship training under the Saudi Commission for Health Specialties includes a research project with a set timeline, and the scleral disorders research proposal is the document prepared at the outset and cleared by the institutional review board before recruitment starts.

United Arab Emirates — DHA, DOH Abu Dhabi and MOHAP. Residents training in Dubai, Abu Dhabi and the northern emirates prepare a scleral disorders research protocol for their programme and submit it for institutional review board approval before any data are collected.

Qatar — DHP (formerly QCHP) and Hamad Medical Corporation. A scleral disorders IRB proposal is reviewed before recruitment, with the ethics section written to the institution's own template rather than a generic one.

Bahrain — NHRA. Trainees turning scleral disorders research topics into a project need the proposal cleared by their institutional research and ethics committee before fieldwork begins.

Oman — OMSB. Residency programmes under the Oman Medical Specialty Board include a research component, and the scleral disorders research proposal is the document assessed at the start of it.

Kuwait — KIMS. A scleral disorders study protocol goes to the institutional committee for approval before the project begins.

Arab Board programmes across the region. The Arab Board carries its own research requirement irrespective of the host country, and the scleral disorders proposal follows the same structure throughout.

Generate a scleral disorders research proposal →

Postgraduate degrees — Malaysia, the Gulf and beyond

Malaysia — MMed, the National Medical Research Register and MREC. A scleral disorders dissertation proposal for a Master of Medicine programme carried out in a Ministry of Health facility must be registered on the NMRR and approved by the Medical Research and Ethics Committee before the study begins, and the guidance asks for submission four to six months ahead of data collection. Every investigator on the study team registers on the NMRR as well, so the methodology, ethics and team sections are written in far more detail than an Indian synopsis requires.

PhD and Master's candidates elsewhere. University programmes generally require a full scleral disorders research proposal of roughly 6,000 to 10,000 words, with an extended literature review, a theoretical framework and a detailed methodology chapter.

PhD and MMed proposals are written individually by a medical doctor and revised until the supervisor accepts them. They are not produced by the automated protocol generator.

Enquire about a scleral disorders PhD or MMed proposal →

🔥 Trending research areas in Scleral Disorders for 2026–27

Current scleral research is increasingly focused on diagnostic differentiation, imaging biomarkers and links between ocular inflammation and systemic disease.

  • Anterior segment OCT in active scleritis: scleral thickness, localised thinning and treatment response can be studied quantitatively when scan location and measurement rules are fixed.
  • Posterior scleritis imaging: B-scan ultrasonography, OCT subretinal fluid, choroidal folds and posterior coat thickening are useful because clinical presentation can mimic retinal or choroidal disease.
  • Infectious versus immune-mediated scleritis: postoperative, traumatic and fungal disease remain important because misclassification can lead to inappropriate corticosteroid exposure and delayed antimicrobial treatment.
  • Systemic inflammatory associations: rheumatoid arthritis, vasculitis, inflammatory bowel disease and other autoimmune disorders offer clinically relevant projects when systemic diagnoses are independently confirmed.

Protocol and synopsis guidance

What a Scleral Disorders protocol must contain

Define the anatomical and aetiological subtype precisely. Episcleritis, diffuse or nodular anterior scleritis, necrotising scleritis, scleromalacia perforans, posterior scleritis and infectious scleritis should have prespecified clinical criteria. Infectious and immune-mediated inflammation should not be pooled unless the analysis explicitly separates them.

Standardise clinical and imaging measurements. Pain score, tenderness, vascular congestion, scleral thinning, nodule size and imaging measurements should be recorded using the same method and time point. For anterior segment OCT, define scan location, measurement plane, image-quality criteria and how the posterior scleral boundary will be identified. For posterior scleritis, specify the B-scan technique and how posterior coat thickening is measured.

State the reference standard. Specialist clinical diagnosis, microbiological culture, systemic physician diagnosis and multimodal imaging answer different questions. A study of infectious scleritis should distinguish clinical suspicion from microbiological confirmation, while posterior scleritis may require a combined clinical and imaging reference rather than a single test.

Record prior treatment and systemic disease. Previous corticosteroid, antimicrobial or immunosuppressive therapy can alter both clinical appearance and microbiological yield. Systemic autoimmune disease should be physician-confirmed when used as an exposure or reference diagnosis, and screening laboratory abnormalities should not automatically be treated as systemic disease.

Scleral Disorders synopsis versus Scleral Disorders protocol

The synopsis gives the compact research plan. It should identify the scleral condition, study population, principal clinical or imaging variable, reference diagnosis, primary outcome, study design and proposed analysis.

The protocol provides the reproducibility details. It should specify clinical grading criteria, pain assessment, imaging device and scan location, microbiological sampling, prior treatment exposure, systemic evaluation pathway, observer masking where relevant, and follow-up timing.

Scleral studies are vulnerable to diagnostic misclassification. Redness and pain alone do not distinguish episcleritis, immune-mediated scleritis and infection, while posterior scleritis may resemble choroidal or retinal disease. The protocol should therefore define how the final diagnosis will be established before outcomes are analysed.

Sample size and statistical analysis

Base sample size on the primary question. Correlation studies use an anticipated correlation coefficient, comparative studies use the expected difference in pain, inflammation or scleral thickness, diagnostic-accuracy studies use expected sensitivity or specificity with disease prevalence, and descriptive studies use an expected proportion with chosen precision.

Respect eye-level and patient-level data. Bilateral scleritis, fellow-eye imaging comparisons and recurrent disease create correlated observations. A protocol should prespecify one study eye, use paired analysis where appropriate or apply methods that account for within-person clustering.

Use analysis that matches the measurement objective. Correlation between OCT-measured scleral thickness and clinical severity is different from agreement between two observers or two methods. Diagnostic studies require sensitivity and specificity against a stated reference standard, while repeated follow-up measurements require paired or longitudinal methods. Multivariable models may be needed when systemic disease, prior treatment, infection, delayed presentation or anatomical subtype influence the outcome.

Frequently Asked Questions – Scleral Disorders Thesis Topics (2026–27)

1. How do I choose a feasible Scleral Disorders thesis topic?

For 2026–2027 admissions, choose a question that matches the scleral disease volume actually seen in the department. Episcleritis, anterior scleritis, postoperative scleral inflammation and systemic-association studies are usually more feasible than rare necrotising or posterior scleritis cohorts. If a rare condition is selected, a retrospective archive may provide a stronger thesis than a small prospective series.

2. Which study designs are commonly accepted for Scleral Disorders thesis work?

Useful designs include cross-sectional observational and analytical studies, comparative studies, diagnostic-accuracy studies, observer-agreement studies, method-agreement studies, retrospective record-based studies, case-control studies and short prospective observational follow-up. The design should follow whether the question concerns diagnosis, systemic association, imaging, treatment response or visual outcome.

3. What should I settle with my guide before finalising a Scleral Disorders topic?

Settle the anatomical subtype, infectious or immune-mediated classification, final reference diagnosis, imaging technique, microbiology availability, prior treatment status, systemic evaluation pathway, primary outcome and follow-up point. If anterior segment OCT or B-scan measurements are central to the study, agree on the exact measurement location and quality criteria before recruitment.

4. How should I standardise scleral imaging measurements?

Use the same device, scan orientation, anatomical location and measurement rule throughout the study. For anterior segment OCT, document how the scleral boundaries are identified and how localised thinning or thickening is measured. For posterior scleritis, define the B-scan view and posterior coat measurement method. Poor-quality or ungradable scans should be handled using prespecified repeat or exclusion rules.

5. What is the difference between a Scleral Disorders synopsis and a Scleral Disorders protocol?

The synopsis summarises the research question, rationale, objectives, disease group, principal investigations and analysis. The protocol gives the operating definitions, anatomical classification, imaging technique, microbiological sampling, systemic evaluation, prior treatment recording, observer roles, study-eye rule, follow-up schedule, missing-data plan and statistical methods.

6. What ethical issues are important in Scleral Disorders research?

Prospective studies require informed consent, and studies involving children require guardian consent with age-appropriate assent from about seven years where feasible. Record-based studies may seek a waiver of consent when permitted by the ethics committee. Research should not delay microbiological sampling, antimicrobial therapy, systemic corticosteroids, immunosuppression or urgent systemic evaluation when these are clinically indicated. Additional imaging beyond standard care should be stated clearly, and research-only venepuncture should have a justified blood-volume limit. Separate consent should be obtained for identifiable anterior-segment photographs or video, and imaging files should be anonymised. The protocol should define an escalation pathway for scleral necrosis, impending perforation, severe infectious scleritis, posterior scleritis with major visual loss or suspected systemic vasculitis requiring urgent multidisciplinary care.

7. Can culture-negative suspected infectious scleritis be classified as immune-mediated scleritis?

No. A negative culture does not by itself exclude infection. Prior antimicrobial treatment, previous corticosteroid use, inadequate sampling, deep scleral involvement and low organism load can reduce microbiological yield. The protocol should keep clinical suspicion, culture result and final aetiological classification as separate variables. If culture positivity is required for confirmed infectious scleritis, clinically suspected culture-negative cases should remain a separate category unless an alternative diagnosis is established by prespecified criteria.

8. Can a Scleral Disorders thesis also support PhD or Gulf board research pathways?

Yes, but the expected scope differs. A PhD proposal usually requires a broader research gap, stronger methodological justification and a programme of work beyond the scope of an MS dissertation. An MS synopsis is usually centred on one feasible dissertation question. SCFHS and Saudi Board trainees may also complete a mandatory board research project, while Arab Board of Health Specializations and DHP, DHA, DOH or MOHAP-linked programmes may use separate proposal, ethics and submission pathways. The scientific topic may overlap, but the document should be written for the intended programme.

9. When should I register my Scleral Disorders thesis topic?

Register after confirming adequate case volume or a sufficiently complete retrospective archive, reliable access to the required imaging or microbiology, guide agreement on the final disease classification and primary outcome, and a follow-up interval that fits the dissertation timeline. Prospective recruitment or research-specific investigations should begin only after the required institutional and ethics approvals are complete.

Found a topic that fits your department?

Generate its full protocol — objectives, methodology, sample size, statistics, timeline, references and annexures — in editable format.

Generate your protocol
Don`t copy text!
Generate Thesis Protocol / Synopsis
×